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Abstract Homologous proteins (NBAT) which mediate sodium- 
independent transport of neutral as well as basic amino acids and 
cystine when expressed in Xenopus oocytes were recently cloned 
from mammalian kidneys. Mutations in human NBAT have been 
implicated in cystinuria. Here, we show that rat kidney and jeju- 
nal brush border membrane NBAT (85 kDa) is found in associa- 
tion with a 50 kDa protein. The association involves one or more 
interprotein disulfide bonds. Rabbit kidney brush border mem- 
branes and membranes of NBAT cRNA-injected Xenopus 
oocytes also contain such heterodimers. Our data suggest hat the 
heterodimer is the minimal functional unit of NBAT-mediated 
amino acid transport and that the NBAT-associated 50 kDa 
protein could play a role in cystinuria. 
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I. Introduction 
Recently, three laboratories, including ours, independently 
cloned homologous proteins from rat [1,2], rabbit [3], and 
human [4,5] kidneys which, when expressed in Xenopus laevis 
oocytes, induce Na+-independent transport of neutral as well 
as basic amino acids and cystine (system b°'+-like). The cloned 
proteins have been variously named (NAA-Tr, NBAT, D2, 
rBAT). In this communication we will refer to it as NBAT (for 
neutral and basic amino acid transporter). NBAT is primarily 
localized in the brush border membranes (BBMs) of renal tubu- 
lar and jejunal epithelial cells [6,7] where it appears to be in- 
volved in a major cystine transport system [4]. Recent studies 
provide strong evidence that mutations in NBAT gene are 
associated with the defects in cystine and basic amino acid 
transport in the inherited isorder, cystinuria [ 8]. The proposed 
membrane structure of NBAT, however, is unusual for a me- 
tabolite transporter. Thus, we proposed a four membrane- 
spanning domain (MSD) model [1] for which experimental ev- 
idence has recently been presented [9]. This topology is in 
marked contrast o that of other well-characterized mammalian 
metabolite transporters (including the amino acid transporters 
cloned to date) which appear to contain from 8 to as many as 
12 MSDs [10-13]. The atypical topology of NBAT prompted 
the speculation that NBAT is not itself a transporter but is, in 
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fact, a regulatory subunit of a larger transporter complex [2,3]. 
We, therefore, examined the oligomeric organization of NBAT 
and have obtained data which suggest hat the minimal func- 
tional unit of NBAT-mediated transport in kidney and jejunal 
BBMs is a heterodimer containing NBAT (85 kDa) and an- 
other protein (approximately 50 kDa). 
2. Materials and methods 
Protein cross-linking reagents were purchased from Pierce. Six syn- 
thetic peptides representing sequences within rat NBAT were used as 
antigens for the production of rabbit antisera directed against NBAT. 
Details of peptide synthesis, production of the antisera, and evaluation 
of their specificity have been described previously [9,14]. The immuno- 
globulin (IgG) fraction from each antiserum was purified using a rPro- 
tein A antibody purification kit from Repligen (Cambridge, MA). The 
lgGs were used in our experiments either individually or as a mixture 
o fall six IgGs (to increase the sensitivity of detection ofimmunoreactive 
proteins). Tissues were obtained from adult (20~250 g) male Spragu~ 
Dawley rats. 
Brush border membranes (BBMs) from rat kidney and jejunum were 
isolated by a calcium precipitation method [15]. The final BBM pellet 
was suspended in 0.01 M phosphate buffer/0.15M NaCI, pH 7.4, and 
stored as 50 ,ul aliquots (approx. 10/tg protein/ill) at -20°C. SDS 
protein complexes were prepared by heating an aliquot of the BBM 
suspension at 100°C for 5 min in 0.05M Tris-HCl buffer (pH 8.0) 
containing 4% SDS (Tris-SDS) either in the absence or in the presence 
of 5% 2-mercaptoethanol (MSH). The samples (containing 5-10 pg of 
kidney and 50 75/lg of jejunal BBM proteins) were subjected to SDS- 
PAGE on either 8% or 10% gels and electrotransferred to nitrocellulose 
membranes [16]. The blots were blocked with 5% non-fat dry milk and 
then treated with anti-NBAT antibodies (each diluted 1:500). The im- 
munoreactive species were detected with horseradish-conjugated goat 
or donkey anti-rabbit lgG using either the diaminobenzidine procedure 
or the ECL Western blotting procedure (as described in the protocol 
supplied by the manufacturer; Amersham). Protein molecular weight 
standards were either high Mr prestained standards from BRL-Gibco 
or the prestained kaleidoscopic standards from Bio-Rad. 
Covalent cross-linking of proteins in BBMs was carried out in 0.1 M 
triethanolamine-HCl buffer (pH 8.5). In a typical experiment, 5/11 of 
the BBM suspension (about 50 ,ug of protein) was mixed with 25/~1 of 
triethanolamine buffer and 10 14 of 20 mM dimethyl suberimidate 
(DMS; prepared in the triethanolamine buffer just before use). Follow- 
ing incubation (60 rain at 25°C), the mixture was centrifuged at 
43,000 x g for 15 min. The membrane pellet was suspended in 15 ~1 of 
Tris-SDS containing 5% MSH and heated at 100°C for 5 min. The 
sample was then subjected to SDS-PAGE followed by Western analysis 
as described above. 
Details of the synthesis of NBAT cRNA from NBAT cDNA, isola- 
tion of Xenopus laevis oocytes, and microinjection of the oocytes with 
NBAT cRNA have been described previously [1]. Three days after the 
injection (10 ng NBAT cRNA per oocyte), 25 oocytes were homoge- 
nized in 1 ml of TNE buffer (0.05 M Tris-HC1, pH 7.5, 100 mM NaCI, 
1 mM EDTA, 5 mM N-ethylmaleimide (NEM), and 1 mM phen- 
ylmethyl sulfonyl fluoride) and the homogenate c ntrifuged at2,000 x g 
for 10 rain. The supernatant was in turn centrifuged at 140,000 x g for 
30 rain and the membrane pellet so obtained was suspended in 40 gtl 
of Tris-SDS either in the absence of MSH or in the presence of 5% MSH 
and heated at 100°C for 5 min. The SDS extracts were then subjected 
to SDS-PAGE and Western analysis as described above. 
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3. Results and discussion 
3.1. Oligomeric organization of NBAT in brush border 
membranes 
To investigate he possibility that NBAT might be part of a 
larger complex, we subjected rat kidney BBMs to SDS-PAGE 
under educing and non-reducing conditions followed by West- 
ern analysis using NBAT-specific antibodies. Under non-re- 
ducing conditions (i.e. when the BBMs were treated with SDS 
in the absence of MSH), Western analysis gave two major 
immunoreactive bands, one at 85 kDa corresponding to the 
glycosylated NBAT monomer [14], and another, representing 
about 20% of the total NBAT-containing species, at about 135 
kDa (Fig. 1A, lane 1). When BBMs were treated with SDS in 
the presence of MSH all of the NBAT was quantitatively recov- 
ered in the 85 kDa band (Fig. 1A, lane 2), indicating that the 
135 kDa species contains disulfide-linked proteins. The relative 
amount of 135 kDa species varied from about 15-50% of the 
total NBAT-containing species in separate batches of kidney 
BBMs (data not shown). Independent of such variation, only 
the 85 kDa NBAT monomer band was detected in all BBM 
preparations under educing conditions. To determine whether 
the variation in the relative amounts of the 135 kDa species was 
because the disulfide bonds linking individual proteins in the 
135 kDa species are readily reduced by sulfhydryl compounds 
normally present in rat kidney (e.g. glutathione, concentrations 
of which can be as much as 5 mM [17]), a thiol-blocking rea- 
gent, NEM, was included in the buffer used for homogenization 
of kidneys. Western analysis (under non-reducing conditions) 
of BBMs prepared in this manner showed that the 135 kDa 
species now consistently accounts for as much as 90% of the 
total NBAT-containing molecules (Fig. 1B, lanes 1 and 2), and 
only the NBAT monomer (85 kDa) was seen when these BBM 
samples were subjected to SDS-PAGE under reducing condi- 
tions (Fig. 1B, lanes 3 and 4). In all of the Western blots shown 
in Fig. 1, an equimixture of the six anti-NBAT IgGs was used. 
Qualitatively similar esults were obtained when each of the six 
IgGs was used individually (data not shown). 
E; 
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Chemical cross-linking has been widely used to investigate 
the subunit organization of membrane-bound proteins [18]. 
Fig. 1C is a representative Western blot of kidney BBMs (pre- 
pared in the absence of N EM) cross-linked with DMS and then 
subjected to SDS/PAGE (under reducing conditions). The 
major cross-linked species exhibits a molecular mass of about 
135 kDa, a size equal to that of the disulfide-linked species 
shown in Fig. lB. Longer incubations with DMS did not influ- 
ence the relative amount of the cross-linked species produced. 
Qualitatively similar results were obtained when cross-linking 
with DMS was carried out on BBMs pretreated with Lubrol 
WX, a non-ionic detergent (data not shown), indicating that the 
components of the 135 kDa species remain associated even 
when the membrane structure is disrupted by a detergent. The 
135 kDa cross-linked species was also produced when the 
BBMs were treated with bis-(sulfosuccinimidyl)suberate (BS3),
a membrane-impermeant cross-linking reagent. Thus, the pro- 
teins constituting the 135 kDa complex are at least partially 
exposed on the outer surface of the BBMs. 
In addition to kidney BBMs, NBAT is also concentrated in 
jejunal BBMs [6]. Rat jejunal BBMs were isolated in the pres- 
ence of NEM and subjected to SDS/PAGE and Western anal- 
ysis. Under non-reducing conditions, almost all NBAT mi- 
grated as the 135 kDa species (Fig. 2A, lane 1). Under reducing 
conditions, only the 85 kDa NBAT monomer band was seen 
(Fig. 2A, lane 2). Furthermore, Western analysis of rabbit kid- 
ney BBMs indicated that, in this species also, a large fraction 
of NBAT (the glycosylated NBAT monomer in rabbit is about 
90 kDa) migrates as a complex of about 150 kDa when the 
BBMs are subjected to SDS-PAGE under non-reducing condi- 
tions (Fig. 2B). For detection of rabbit NBAT, the anti-lgG 
directed against rat NBAT sequence 527-539 (Ab527) was used 
(the corresponding sequence in rabbit NBAT differs in only the 
first residue, which in rat is Asn [1] and in rabbit is Ser [3]). As 
in rat kidney, the relative amounts of the disulfide-linked spe- 
cies in different batches of the rabbit kidney BBMs also varied, 
and when NEM is included in buffers during BBM isolation, 
the 150 kDa species (presumably analogous to the 135 kDa 
A [3 
I 
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Fig. 1. Western analysis of NBAT from rat kidney brush border membranes. (A) Aliquots of the BBM suspension (about 50/~g of protein) were 
heated with SDS either in the absence (lane 1) or in the presence (lane 2) of 2-mercaptoethanol (MSH), subjected to SDS-PAGE followed by 
electroblotting of the proteins on a nitrocellulose membrane. The transferred proteins were detected, inthis experiment and in experiments shown 
in panels B and C, using a mixture of all six anti-NBAT IgGs and the diaminobenzidine procedure. Arrowheads indicate position of the immunoreac- 
tive 135 (upper band) and the 85 kDa (NBAT subunit; lower band) species. The protein standards a,b and c are, respectively, 200, 97.4, and 68 kDa. 
(B) Western analysis of rat kidney BBMs isolated using buffers containing either 5 mM NEM (lanes 1 and 3) or 10 mM NEM (lanes 2and 4). Lanes 
1 and 2 show results obtained with membranes treated with SDS without MSH; lanes 3 and 4 show results of experiments in which the BBMs were 
treated with SDS in the presence ofMSH prior to SDS/PAGE. Arrowheads mark the position of the 135 (upper band) and 85 kDa (lower band) 
species. Standards a,b, and c are, respectively, 202, 133, and 71 kDa. The band above the 202 kDa standard in lanes 1 and 2 are proteins at the 
top of the gel (presumably higher aggregates containing NBAT). (C) BBM proteins were cross-linked with either 5 mM or 2.5 mM dimethyl 
suberimidate (DMS) (lanes 1 and 2, respectively). Following DMS treatment (for 60 min at 25°C), the membranes were heated with SDS in the 
presence of5% MSH, subjected toSDS-PAGE and Western analysis. Lane 3 is an untreated BBM control. The protein standards a,b, and c are, 
respectively, 200, 97.4, and 68 kDa. 
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Fig. 2. Western analysis of NBAT in rat jejunal and rabbit kidney 
BBMs. (A) Aliquots of rat jejunal BBMs (about 75/~g protein), isolated 
using buffers containing NEM, were subjected to SDS-PAGE followed 
by Western analysis using a mixture of all six anti-NBAT IgGs and the 
diaminobenzidine procedure for detection of the immunoreactive spe- 
cies. Lane 1 = BBMs treated with SDS without MSH; lane 2 -- BBMs 
treated with SDS plus MSH. Arrowheads mark the position of the 135 
kDa (upper band) and the 85 kDa (NBAT subunit; lower band) species. 
(B) Aliquots of rabbit kidney BBMs, isolated in the absence of NEM 
(about 10/lg of protein), were subjected to SDS-PAGE followed by 
Western analysis using Ab527 [9]. Left lane = SDS treatment in the 
absence of MSH; right lane = SDS treatment in the presence of MSH. 
Immunoreactive species were detected usingthe ECL procedure. Ar- 
rowheads mark the 150 kDa (upper band) and the 90 kDa (NBAT 
subunit; lower band) species. Molecular mass standards a,b, and c are, 
respectively, 202, 133, and 71 kDa. Identity of the species in the 75 kDa 
region seen in both lanes is not known. Its intensity isnot affected by 
presence or absence of MSH. It might represent a degradation product 
of NBAT. 
to those found in these two organs. Such sites include certain 
enteroendocrine c lls and enteric neurons [6], chromaffin cells 
of the adrenal medulla, and some of the catecholamine-contain- 
ing neurons of brainstem and spinal chord [19]. Further studies 
are also required to determine whether the proteins found in 
association with NBAT can also occur on their own and/or in 
association with other proteins and, thus, possibly participate 
in additional transport and other functions. 
3.2. Relationship of the heterodimer to transport 
The heterodimeric model for NBAT-mediated transport, 
however, does not satisfactorily provide an explaination for the 
observations that system b°'+-like amino acid transport can be 
expressed in Xenopus oocytes [1-5] from NBAT cRNA alone. 
We considered the possibility that NBAT, synthesized in 
oocytes from injected cRNA, associates with a protein (or pro- 
teins) endogenous in oocytes to generate the functional heter- 
odimer. Fig. 3 shows a Western analysis of oocyte membranes 
(isolated in the presence of NEM) 3 days after injection of 
NBAT cRNA. The membranes were subjected to SDS-PAGE 
under both reducing and non-reducing conditions. Under re- 
ducing conditions, only the 87 and 89 kDa bands representing 
the glycosylated NBAT monomers produced in oocytes [14] are 
seen (Fig. 3, lane 1). Under non-reducing conditions, however, 
additional bands are seen in the 180-200 kDa region (presum- 
ably representing homodimers of NBAT subunits) (Fig. 3, lane 
2, open circles), and at about 135 and 140 kDa (Fig. 3, lane 2, 
arrowheads). Since NBAT cRNA can direct synthesis of only 
the 87-89 kDa NBAT subunits, it follows that the formation 
of 135 and 140 kDa species must involve association of NBAT 
with approximately 50 kDa protein(s) of oocyte origin. The 
resultant heterodimers are similar in size to those seen in rat 
kidney and intestine and, thus, might perform similar func- 
tion(s) in oocytes (i.e. system b°'+-like amino acid transport 
activity). If formation of such a heterodimer is, indeed, a pre- 
requisite for expression of transport activity, the upper limit of 
induced transport must then depend upon the available 
amounts of the 50 kDa protein in oocytes. Such a scenario 
complex in rat kidney) accounted for about 80% of all NBAT- 
containing moieties (data not shown). 
The size of the disulfide-linked (as well as the chemically 
cross-linked) species in rat kidney and jejunum (135 kDa) is 
significantly less than that expected for a homodimer contain- 
ing two NBAT subunits (expected size, about 170 kDa). We 
have never observed species, either disulfide-linked or chemi- 
cally cross-linked, intermediate in size between 85 kDa and 135 
kDa. The most likely structure, therefore, for the 135 kDa 
species is that of a heterodimer consisting of an NBAT subunit 
and a 50 kDa protein. The finding that NBAT in two different 
tissues of the rat (kidney and jejunum) and in kidneys from two 
different species (rat and rabbit) is associated with a smaller 
protein indicates that such a heterodimer most probably repre- 
sents the minimal functional unit for the NBAT-mediated 
amino acid transport. Elucidation of the precise role of pro- 
tein(s) associated with NBAT will require its isolation and 
molecular characterization. It would also be of interest to deter- 
mine whether NBAT found in locations other than the kidney 
and intestine is also part ofheterooligomeric complexes imilar 
Fig. 3. Western analysis of NBAT and NBAT-containing species in 
membranes ofXenopus oocytes injected with NBAT cRNA. Three days 
after the injection of NBAT cRNA (10 ng per oocyte), the oocyte 
membranes were isolated (in the presence of NEM), aliquots treated 
with SDS either in the presence of MSH (lane l) or in its absence (lane 
2), subjected to SDS-PAGE and Western analysis using a mixture of 
the six anti-NBAT IgGs. The immunoreactive species were detected 
using the ECL procedure. X marks the position of NBAT subunits (two 
closely spaced bands at about 87 and 89 kDa, respectively); arrowheads 
indicate the NBAT-containing species, approximately 135 kDa (lower 
band) and 140 kDa (upper band), respectively; and open circles denote 
the NBAT-containing oligomers, approximately 180-200 kDa (pre- 
sumably homodimers of NBAT subunits). The standards a, b, and c 
are, respectively, 202, 133, and 71 kDa. 
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could explain the previously reported results which showed 
that, while the amount of the total NBAT synthesized in 
oocytes increased greater than 10-fold between 24 and 48 h 
following the injection of NBAT cRNA, the rate of amino acid 
uptake increased only about 1.5-fold [14]. Note that the higher 
Mr aggregates seen in oocyte membranes, corresponding in size 
to that expected for homodimers of NBAT subunits (Fig. 3, 
lane 2, open circles), were absent in rat kidney and jejunal 
BBMs, and, thus, must be presumed to have no physiological 
significance.Their formation in oocytes may be a consequence 
of the greater density achieved by the expressed NBAT in 
oocyte membranes. 
We had previously found that although NBAT can be ex- 
pressed in COS-7 cells transfected with NBAT cDNA, no sig- 
nificant increments in amino acid uptake clearly ascribable to 
the expressed NBAT could be demonstrated [14]. The explana- 
tion given then was that the basal endogenous rate of amino 
acid uptake by COS-7 cells is already so high that the increase 
in transport due to the expressed NBAT is difficult to distin- 
guish. An alternate xplanation for the failure to detect induc- 
tion of transport activity despite synthesis of NBAT could be 
that the 50 kDa or similar proteins required for the formation 
of functionally competent heterodimers are absent in COS-7 
cells. This, indeed, appears to be so since Western analysis of 
membranes from NBAT cDNA-transfected COS-7 cells, under 
non-reducing conditions, failed to reveal NBAT-containing 
species in the 135-140 kDa range, although intense bands cor- 
responding to the NBAT monomers (about 87 kDa) and higher 
Mr species in the 200 kDa range, presumably homodimers, were 
readily visible (data not shown). 
NBAT has recently generated considerable interest in wake 
of the finding that mutations in human NBAT gene segregate 
with cystinuria [8]. Cystinuria is an autosomal recessive disease 
caused by an amino acid transport defect in renal and intestinal 
BBMs resulting in excessive urinary excretion of cystine and 
basic amino acids [20]. It is one of the most common genetic 
disorders, the clinical manifestation of which is the develop- 
ment of kidney stones resulting from the poor solubility of 
cystine. Yan et al. [21] localized human NBAT gene to the p21 
region of chromosome 2; this is consistent with the earlier 
finding that the gene causing cystinuria maps to chromosome 
2p markers [22]. These observations, along with discovery of 
mutations within the NBAT gene amongst cystinurics [8], indi- 
cate that NBAT is most likely a cystinuria gene. However, the 
possibility that other genes might also be involved must be 
considered in view of the fact that at least three types of cystin- 
urias have been described, each with a characteristic biochem- 
ical and genetic pattern [20]. Furthermore, a case associated 
with cystinuria nd mental retardation has been described in- 
volving a de novo balanced translocation [14,20], suggesting 
that one of these breakpoints (14q22 or 20p13) might also lead 
to cystinuria [23]. In view of this, our finding that NBAT- 
associated transport might require another protein (50 kDa) 
acquires pecial significance. Molecular characterization f this 
protein and elucidation of its function in cystine transport will 
be required to define its role in cystinuria. 
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